SEC Form 4 · accession 0001104659-16-091473
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah O. Kalil
Officer — Chief Operating Officer
Period of report
Jan 20, 2016
Accepted (ET)
Jan 26, 2016 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $9.02 | Jan 20, 2016 | A | 40,000 | A | — | Jan 19, 2026 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The stock option vests in 48 monthly installments commencing January 20, 2016.